Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Sep 10 2019

Full Issue

Depression Drug Spravato Reduces Symptoms In 24 Hours For People Considering Suicide, Studies Find

The trials, done by the drug's maker Johnson & Johnson, might yield important treatment information for severely depressed patients because other treatments can take weeks to go into effect. Mental health news looks at suicide rates, telemedicine, positive relationships early in life, and first responders, as well.

NPR: Spravato May Ease Depression In Suicidal Patients

The depression drug esketamine, marketed as Spravato, appears to offer quick relief to people who are actively considering suicide. Esketamine, a chemical cousin of the anesthetic and party drug ketamine, reduced depression symptoms within hours in two large studies of suicidal patients, the drug's maker announced Monday. (Hamilton, 9/9)

Reuters: Suicide Kills One Person Every 40 Seconds, Says WHO

Across the world, one person takes their own life every 40 seconds, and more people die by suicide every year than in war, the World Health Organization said on Monday. Hanging, poisoning and shooting are the most common suicide methods, the WHO said as it urged governments to adopt suicide prevention plans to help people cope with stress and to reduce access to suicide means. (9/9)

NPR: Telemedicine Aids Recruiting Of Psychiatrists And Access To Care

It used to take at least nine months for a patient to schedule an initial appointment with a psychiatrist at Meridian Health Services in Indiana. Now, it takes days, thanks to a program that allows doctors to connect over the Internet with patients, reaching those even in remotest corners of the state. That has also helped with recruitment. Over the last several years, Meridian's staff of psychiatric specialists, including nurse practitioners, tripled from four to 12. (Noguchi, 9/9)

NPR: Positive Relationships In Childhood Can Prevent Depression Later In Life

Plenty of research shows that adverse childhood experiences can lead to depression and other health problems later in life. But researcher Christina Bethell wondered whether positive experiences in childhood could counter that. Her research comes from a personal place. In the 1970s, in a low-income housing complex in Los Angeles, Bethell had a tough childhood. Sometimes she didn't have money for lunch. (Simmons-Duffin, 9/9)

The Washington Post: New Survey Shows Heavy Psychological Toll For Virginia’s First Responders

A first-of-its-kind mental health survey of police, firefighters and 911 call dispatchers in Virginia finds that they experience suicidal thoughts at a rate of more than double the general population and that nearly a quarter suffer from work-related depression. The survey of nearly 4,900 first responders also found that nearly half couldn’t stop looking for threats even in their own homes, a common symptom for those who have been exposed to trauma. (Jouvenal, 9/10)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF